Back to FRANKLIN TEMPLETON INC FRANKLIN TEMPLETON INC

ACETACET
3 quarters

Position history for FRANKLIN TEMPLETON INCFRANKLIN TEMPLETON INC's holdings in ADICET BIO INC

Yes. Franklin Templeton holds 626,571 shares of ACET (Adicet Bio), worth $5.4M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Franklin Templeton has held ACET in every 13F on record since Q4 2025, 3 quarterly filings.

Current Value

$5.4M

Current Shares

626,571

Total Value Change

+$137,845

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
626,571
0.0%
$5.4M0.0%$8.64
0
2026-Q1
Unchanged
626,571
0.0%
$4.3M0.0%$6.81
0
2025-Q4
New
626,571
-
$5.3M0.0%$8.42
37

Other major holders of ACET: RA CAPITAL MANAGEMENT, L.P., Woodline Partners LP, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used